The weight came first, somewhere between fifteen and twenty-five pounds over two years, with no change in what she ate. The 3 AM waking followed, most nights, and then a flatness in her mood that her partner noticed before she did, along with a fog in the Tuesday meetings she has run for a decade. Her doctor gave her eight minutes, a basic panel, the word normal, and a prescription for an antidepressant. Nothing else was ordered, and no follow-up was set to find out why three things had changed at once.
She is a composite, built from the situations of many women in their late forties rather than from one real patient, and if parts of her sound like you, this piece is written for you. The question she types late at night is blunt: will my HSA cover midlife hormone labs, and does my insurance count for any of this? The short answers come first. Insurance does not pay the GoodLife Health membership fee. The fee is generally eligible for HSA or FSA pre-tax dollars. Your insurance stays, for the specialist, the scan and the hospital. The rest of this piece shows the year-one numbers on both sides, with their dates, and says plainly who should not buy.
- Insurance does not pay the $299 GoodLife Health membership fee; your plan stays for specialists, imaging and the hospital.
- The fee is generally eligible for HSA or FSA pre-tax dollars; your account administrator confirms it for your plan.
- Four cardiometabolic panels a year sit inside the fee, so the labs your visit never ordered are paid through it.
- Year one is $3,588 plus any medication at your pharmacy's price; insurance-based primary care alone ran $3,300+ before a prescription on KFF averages.
- Whether a medication is covered is between you, your plan and the pharmacy; nothing is promised.
- If your doctor is already working up the weight, sleep and mood together, keep that doctor.
Two years, eight minutes and one prescription
Start with what happened in the room, because it shapes the money question. The appointment was booked as a routine visit, and the panel drawn was the basic one: a blood count, a metabolic panel, a cholesterol number, perhaps a TSH. Everything came back inside the reference range, which is what the word normal means on a lab report. A reference range describes where most of a population falls. It cannot tell you whether a marker has moved for you, because nobody drew the same markers two years ago to compare against.
The antidepressant may be the right medicine for her, or it may not. That is a clinical question, and she deserves someone who answers it with her chart open and her history in front of them. What troubled her was narrower. The weight, the sleep and the mood arrived together, and the visit addressed one of them. Fasting insulin, free T3 and free T4, estradiol, progesterone and testosterone were not drawn. Nobody asked whether the three changes shared a cause, and no second appointment was offered to look.
She has a GP and likes him well enough. His schedule is built in short slots for a large panel of patients, which is the system he works inside and the system her insurance pays for. She has been dismissed before, by more than one clinician, about more than one thing, and part of her wonders whether she is overreacting. Two years of change in three places at once is a reasonable thing to want explained. She wants a workup, and she is a careful buyer who wants to know what it costs before she commits to one.
So the first thing she feels about a membership is resentment at paying twice. She already pays a premium through work. She already carries a deductible. She has an HSA with a balance that keeps growing because she rarely touches it. If she pays $299 a month on top, does any of that money count? The resentment is fair, and the answer has three parts: what insurance pays for, what the HSA is for, and what a year actually costs on each side.
What your insurance paid for, and what nobody paid for
Insurance-based primary care runs on the billed visit. The plan pays for an appointment and the tests attached to it, inside rules about what is covered and for whom. Our ROI guide, built on published figures as of September 2026, puts the typical visit at 8–18 minutes. A clinician can screen in that time, and screening is what the basic panel does: it looks for conditions that announce themselves in a single draw. A workup asks a different question, why this particular person changed, and it needs more markers, read together, then drawn again.
Her insurance paid for the visit it was built to buy, and nobody bought the workup.
Asking that question inside insurance often lands on the patient. A plan may decline a fuller panel it does not consider indicated, and the same guide puts a hormone panel at $150 to $400 out of pocket. The plan itself is far from free. The KFF 2025 Employer Health Benefits Survey found the average employee contributes $1,440 a year in premiums and faces a $1,886 deductible before most care is covered. Our guide's year-one estimate for insurance-based primary care alone is $3,300 or more, before a single prescription.
None of this makes insurance a poor purchase. It does the job it was designed for: the emergency, the surgery, the specialist, the scan, the hospital bill that would otherwise follow a family for years. It is a weak fit for the slow problem that unfolds quarter by quarter, where the value comes from the same clinician reading the same markers again three months later and seeing which way they moved.
Medicine has been moving toward that slower work, and the movement shows in dated facts. In the practices doing this work, testing comes before treating, and ApoB and fasting insulin are read where LDL and glucose used to be the whole story. Membership care is replacing the eight-minute visit for patients who want a clinician with time. The manufacturers of branded GLP-1 medication now publish their own self-pay prices, so a patient can see what the drug costs at the source. And the labeling on hormone therapy changed in February 2026, which means a conversation she may have been told to skip deserves a fresh hearing, with someone who reads her own numbers.
The HSA answers a different question from insurance. Insurance decides what it will pay for. An HSA or FSA holds your own money, set aside before tax, for qualifying care. The GoodLife Health membership fee is generally eligible for HSA or FSA pre-tax dollars. Generally is the honest word, because plans and administrators differ, and your account's administrator is the one who confirms it for you. Because the four quarterly panels sit inside the fee, the labs her visit never ordered are paid through that same fee, and so through the same dollars.
The membership against staying in-network, priced for year one
Here is what the membership does about the workup she did not get. A clinician licensed in her state takes the history: the two-year timeline, the antidepressant, the sleep, the cycle if she still has one. The clinician orders a cardiometabolic panel with thyroid, sex hormones and metabolic markers read together, and every result goes into her hands. The panel is drawn every quarter, four times a year, so the second draw can show what the first could not, the direction of travel. She messages the care team in writing between visits, the visits are by video, and the clinician who reads the first panel is the one who reads the fourth.
If treatment is indicated, it may be hormone therapy, thyroid medication, a branded GLP-1 such as Wegovy or Zepbound, or another FDA-approved medication the clinician judges right for her. It may also be nothing new at all. The fee is the same in every case, with no molecule upcharge and no dose upcharge.
Whether hormone therapy, thyroid medication or any other medication is indicated is a clinician's decision, made from your panel and your history. If you have started an antidepressant, keep taking it as prescribed and raise it at intake; nothing in this piece is a reason to stop it.
Medication is where insurance can come back into the picture, on its own terms. Prescriptions go to the pharmacy she chooses, at that pharmacy's own price; GoodLife Health sets nothing, sees nothing and takes nothing on medication. Whether her plan covers a given medication is between her, the plan and the pharmacy. If the plan requires prior authorization, that is the pharmacy's process, and we never claim to run it, speed it or win it. For the hormones most often prescribed in midlife, our hormone pricing guide lists what the pharmacy charges. For GLP-1 medication, the manufacturers publish their own self-pay prices. As of September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills, an introductory offer for new patients through December 2026, and $349 a month after, with the Wegovy pill from $149 a month at lower doses. LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose.
Year one: the membership against staying in-network
| Line | GoodLife Health membership | Insurance-based primary care only |
|---|---|---|
| Annual fee | $3,588 ($598 at sign-up for the first two months, then $299 a month) | $0 membership |
| Visits | A clinician who stays, by video, with messaging between visits | Whatever your plan covers, at 8–18 minutes a visit |
| Labs | Four cardiometabolic panels a year in the fee, every result in your hands | Plan-dependent; a hormone panel $150–$400 out of pocket |
| Medication | Prescribed when indicated to your pharmacy at its own price; nothing taken on it | Through your plan and your pharmacy |
| Insurance | Kept for specialists, imaging and hospital care | $1,440 average employee premium, $1,886 average deductible, plus copays |
| Paid with | Your own money; the fee generally HSA or FSA eligible | Premiums, deductible and copays |
| Year one, all-in | $3,588 plus medication, with insurance kept for catastrophic care | $3,300+ before a single prescription |
| Prices dated | Membership as of October 2026; medication per the manufacturers, September 2026 | KFF 2025 survey, as used in our September 2026 ROI guide |
Read the two columns for what they are: two ways of getting primary care, sitting on top of the same insurance. Her premium and deductible stay in both, because the membership pairs with insurance for catastrophic coverage and does not replace it. What changes is the primary-care relationship. In the membership column, the eight-minute visit gives way to a clinician who stays and four panels a year paid through one fee. In the in-network column, the visit stays as it was, and any fuller panel is a case-by-case cost on her own card.
A concierge practice is the other option she might weigh. Our ROI guide puts mid-tier concierge retainers at $1,500 to $5,000 a year (September 2026), for a smaller panel and longer visits, with the visits still billed to insurance and ongoing labs and hormone protocols varying by physician. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and says so.
We do not argue price with the $99 app. The argument is about incentives. A model that earns on the prescription has a reason to write one, while a membership that earns the same $299 whether the answer is a medication or none has no such reason. She has already been handed one prescription without a workup, and a second would not help her.
Not everyone is accepted. The path is the eligibility check, the intake, the checkout, then a clinician's review. If the clinician cannot accept her into care, the $598 is refunded in full; once she is accepted, the first two months are non-refundable.
What she can do this week, whether or not she joins
None of this requires a decision today. These steps are useful either way.
- Ask the HSA or FSA administrator, in writing, whether a direct primary care membership fee qualifies under her plan, and keep the reply.
- Request every lab result from the last two years through the patient portal and note beside each one which markers were drawn. If fasting insulin, free T3, free T4 or the sex hormones are absent, she now knows what normal was measured against.
- Write the timeline on one page: when the weight changed, when the sleep went, when the mood followed, what happened to her cycle, any new medication. Any clinician, ours or her current one, can do more with that page than with a memory recited in a short slot.
- Ask her plan what a fuller hormone and metabolic panel would cost her if ordered, so the comparison above is made with her own numbers.
- If she would rather stay with her doctor, book a longer follow-up for these three changes specifically, and ask directly what might explain them together.
If low mood has become something that frightens her, or anyone reading this, the call goes to her doctor or to emergency services today. A membership built on quarterly labs is the slow work, and it is not crisis care.
Who this is not for
If you want insurance to pay for everything, this is the wrong purchase. The membership fee is yours to pay, generally with HSA or FSA dollars, and your premium does not shrink because you join. If your current doctor is already working up the weight, the sleep and the mood together, with a fuller panel and a plan to repeat it, keep that doctor; you do not need us. If you want a prescription within a day for $99 and no labs, we will not compete for that, and you should buy it elsewhere. If you are looking for a promise that hormone therapy, a GLP-1 or weight loss is coming, we make none: the clinician decides from the panel, and the answer may be no new medication at all. And if you are healthy, see a doctor twice a year and take no medication, our own ROI guide says you will not recoup $3,588 in a year.
For everyone else, here is the offer, plainly. The GoodLife Health membership is $299 a month. $598 is charged at sign-up and covers the first two months; after that it is month to month. If the clinician cannot accept you into care, the $598 is refunded in full; once you are accepted, the first two months are non-refundable, and any medication billed by a pharmacy follows that pharmacy's own return and refund policy. The fee buys four cardiometabolic panels a year with every result in your hands, a clinician who stays and reads each panel against the last, messaging and video visits, and medication prescribed when indicated to your pharmacy at that pharmacy's price, with nothing taken on it. Insurance does not pay the fee; HSA or FSA dollars generally can, and your insurance stays for everything outside primary care. What it returns is the workup your visit never produced, markers followed quarter by quarter, and no repeat of the eight-minute visit. It is different because it tests first, treats second, and sells neither the drug nor the dose. The reason to start now is in your own timeline: two years of change with no baseline drawn, and every quarter without one is a quarter you cannot compare against later.
Related Reading
- The Real ROI of a $299/Month Health Membership: Every Alternative, Priced Honestly
- Bioidentical Hormone Therapy at Pharmacy Cost: The Real Numbers
References
- 2025 Employer Health Benefits Survey — Kaiser Family Foundation. 2025. www.kff.org/health-costs/2025-employer-health-benefits-survey/
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings